Good reasons to krow

QuickView | Media | 22/01/2019

Spatial awareness

Outlook | Technology | 22/01/2019

CEE office landlord of choice

Outlook | Property | 22/01/2019

Another performance fee to bolster FY19

Update | Financials | 22/01/2019

Sandfire’s bid undervalues MOD

Update | Mining | 22/01/2019

FY18 revenue growth of 14% confirmed

Update | Technology | 22/01/2019

Growth accelerating in H218

Flash note | Industrial Support Services | 21/01/2019

Reassuring update

Update | Financials | 18/01/2019

SEL120 to enter clinical development in 2019

Outlook | Pharmaceuticals & healthcare | 18/01/2019

21% total return in H1 continues strong growth

Update | Property | 17/01/2019

New year, renewed focus

Update | Pharmaceuticals & healthcare | 17/01/2019

Resilience over the peak trading period

Update | Consumer Support Services | 17/01/2019

Keeping it real

Initiation | Industrial Support Services | 14/01/2019

Keeping its eye on longer-term growth

Outlook | Financials | 14/01/2019

Strong finish to FY18

Update | Technology | 14/01/2019

FY18 growth confirmed

Update | Technology | 14/01/2019

Revising forecasts to reflect weaker semis sector

Update | Technology | 14/01/2019

Positive interim six-month Prima data

Flash note | Pharmaceuticals & healthcare | 11/01/2019

On course

Update | Financials | 11/01/2019

Termination of coverage

Termination | Investment Companies | 10/01/2019

Termination of coverage

Termination | Mining | 10/01/2019

Termination of coverage

Termination | Pharmaceuticals & healthcare | 10/01/2019

Termination of coverage

Termination | Oil & gas | 10/01/2019

Derazantinib interim iCCA data promising

Update | Pharmaceuticals & healthcare | 10/01/2019

Termination of coverage

Termination | Technology | 10/01/2019

Termination of coverage

Termination | Pharmaceuticals & healthcare | 10/01/2019

Termination of coverage

Termination | Technology | 10/01/2019

Termination of coverage

Termination | Oil & gas | 10/01/2019

Termination of coverage

Termination | Industrial Support Services | 10/01/2019

Termination of coverage

Termination | Pharmaceuticals & healthcare | 10/01/2019

Termination of coverage

Termination | Pharmaceuticals & healthcare | 10/01/2019

Termination of coverage

Termination | Technology | 10/01/2019

Termination of coverage

Termination | Mining | 10/01/2019

Termination of coverage

Termination | Pharmaceuticals & healthcare | 10/01/2019

Termination of coverage

Termination | Mining | 10/01/2019

Termination of coverage

Termination | Pharmaceuticals & healthcare | 10/01/2019

Termination of coverage

Termination | Pharmaceuticals & healthcare | 10/01/2019

Termination of coverage

Termination | Pharmaceuticals & healthcare | 10/01/2019

An exceptionally strong end to the year

Update | Food & Drink | 09/01/2019

On track to meet income targets

Update | Property | 09/01/2019

South Disouq first gas and H219 drilling

Update | Oil & gas | 08/01/2019

Good start to FY19

Update | Consumer staples | 08/01/2019

Biscathorpe-2 - a material catalyst for Egdon

Flash note | Oil & gas | 07/01/2019

Capital base is boosted

Update | Technology | 07/01/2019

Established vehicle with new engine for growth

Review | Investment Companies | 07/01/2019

Increasingly positive view on UK market outlook

Initiation | Investment Companies | 07/01/2019

Trade dispute weighing on investor sentiment

Review | Investment Companies | 07/01/2019

Test sales up 43% in H119

Update | Pharmaceuticals & healthcare | 07/01/2019

M69 aircrew mask systems success

Flash note | Aerospace & Defence | 07/01/2019

Retaining lefitolimod’s value

Update | Pharmaceuticals & healthcare | 04/01/2019

Open season on Exosome deals

Flash note | Pharmaceuticals & healthcare | 04/01/2019

ASX listing expected as funding is confirmed

Update | Oil & gas | 04/01/2019

Positive reinvestment of residential proceeds

Flash note | Property | 04/01/2019

Promising dendritic cell data in AML

Update | Pharmaceuticals & healthcare | 04/01/2019

First multi-cloud deal

Flash note | Technology | 03/01/2019

Nidanilimab transitioning to Phase IIa

Update | Pharmaceuticals & healthcare | 03/01/2019

Milestone payment: On track with major client

Flash note | Technology | 24/12/2018

Affected by industry flux but still performing well

Update | Technology | 21/12/2018

Time to reflect

Outlook | Pharmaceuticals & healthcare | 21/12/2018

FDA OKs 505(b)(2) pathway for LiPlaCis in mBC

Update | Pharmaceuticals & healthcare | 21/12/2018

Positive trading update to November

Update | Consumer Support Services | 21/12/2018

Growth and income from a contrarian portfolio

Review | Investment Companies | 20/12/2018

Long-acting injectable drug delivery vehicle

QuickView | Pharmaceuticals & healthcare | 20/12/2018

Strategic Chess move

Outlook | Aerospace & Defence | 20/12/2018

Give a girl the right pair of shoes…

QuickView | Consumer Support Services | 20/12/2018

Core business order shortfall

Update | Technology | 20/12/2018

Well-positioned going into H2

Update | Construction & Building Materials | 20/12/2018

Re-set dividend expectations, targeting recovery

Update | Basic Industries | 19/12/2018

Tardan CIL >60% complete

Update | Mining | 19/12/2018

TALICIA Ph III top-line data positive

Update | Pharmaceuticals & healthcare | 19/12/2018

Pumping it

Update | Mining | 19/12/2018

Moving to EBITDA positive

Update | General Industrials | 19/12/2018

Building on strengths

Update | Financials | 19/12/2018

CRAziness averted

Update | Mining | 19/12/2018

Growing and investing

Update | Construction & Building Materials | 19/12/2018

Discoveries made, exploration concept validated

Initiation | Mining | 18/12/2018

H1 organic growth supports FY19 outlook

Update | Electronics & Electrical Equipment | 18/12/2018

Finding attractively valued income opportunities

Initiation | Investment Companies | 18/12/2018

Focus on profitable properties

Update | Media | 17/12/2018

Highlighting the opioid dependency market size

Update | Pharmaceuticals & healthcare | 17/12/2018

Encouraging signs in Prima EU feasibility study

Update | Pharmaceuticals & healthcare | 17/12/2018

SEK124m rights issue underway 80% guaranteed

Update | Pharmaceuticals & healthcare | 17/12/2018

Strong long-term absolute performance

Review | Investment Companies | 17/12/2018

Near-term trading distracting from long-term trend

Update | Industrial Support Services | 17/12/2018

Worth listening out for clearSound

QuickView | Technology | 14/12/2018

Location, location, location

Update | Technology | 14/12/2018

Delivering against guidance

Update | Financials | 14/12/2018

Diversified business model

Update | Financials | 14/12/2018

Strong performance delivers growth

Update | General Industrials | 13/12/2018

New partner, strong organic growth prospects

QuickView | Technology | 13/12/2018

$3m cloud contract

Flash note | Technology | 13/12/2018

On track for an inflection in FY20

Flash note | Technology | 13/12/2018

Rewards for keeping the faith

Outlook | Pharmaceuticals & healthcare | 12/12/2018

Full speed ahead on 5G

Update | Technology | 12/12/2018

Preparing to establish own sales organization

ADR Update | Pharmaceuticals & healthcare | 12/12/2018

Disciplined approach driving outperformance

Review | Investment Companies | 11/12/2018

Delivering growth

Outlook | Consumer staples | 11/12/2018

Clinical development in 2019

Update | Pharmaceuticals & healthcare | 10/12/2018

Plain vanilla

QuickView | Consumer Support Services | 10/12/2018

ASH 2018: 50mg cohort on last patient

Update | Pharmaceuticals & healthcare | 10/12/2018